Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Clark

Showing results (131-140 of 384) with videos related to

Pageof 39
Sort By:
European Journal of Heart Failure|May 25, 2012
Heart rate achieved or beta-blocker dose in patients with chronic heart failure: which is the better target?Damien Cullington, Kevin M Goode, Andrew L Clark, et al.
European Journal of Heart Failure|June 30, 2011
Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST IIJohn G F Cleland, Alison P Coletta, Nick Freemantle, et al.
European Journal of Heart Failure|December 11, 2007
Combining the ventilatory response to exercise and peak oxygen consumption is no better than peak oxygen consumption alone in predicting mortality in chronic heart failureLee Ingle, Klaus K Witte, John G F Cleland, et al.
Journal of Cardiac Failure|October 19, 2005
Poor relationship between exercise capacity and spirometric measurements in patients with more symptomatic heart failureLee Ingle, Rhidian J Shelton, John G F Cleland, et al.
European Journal of Heart Failure|July 28, 2009
Clinical trials update from the European Society of Cardiology Heart Failure meeting 2009: CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HFJohn G F Cleland, Alison P Coletta, Azam Torabi, et al.
Journal of the American Geriatrics Society|March 18, 2014
Multiple cardiac clots in an individual with essential thrombocythemia and heart failurePierpaolo Pellicori, Anil C Joseph, Thato Mabote, et al.
European Journal of Heart Failure|August 11, 2004
Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapyAlison P Coletta, John G F Cleland, Nick Freemantle, et al.
European Journal of Heart Failure|January 3, 2006
Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVEJohn G F Cleland, Nick Freemantle, Alison P Coletta, et al.
ESC Heart Failure|February 21, 2017
Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysisJufen Zhang, Riet Dierckx, Kevin Mohee, et al.
JACC. Heart Failure|June 19, 2017
Time to Take the Failure Out of Heart Failure: The Importance of OptimismJohn G F Cleland, Pierpaolo Pellicori, Andrew L Clark, et al.
Pageof 39

Showing results (131-140 of 384) with videos related to

Sort By:
Pageof 39
European Journal of Heart Failure|May 25, 2012
Heart rate achieved or beta-blocker dose in patients with chronic heart failure: which is the better target?Damien Cullington, Kevin M Goode, Andrew L Clark, et al.
European Journal of Heart Failure|June 30, 2011
Clinical trials update from the American College of Cardiology Meeting 2011: STICH, NorthStar, TARGET, and EVEREST IIJohn G F Cleland, Alison P Coletta, Nick Freemantle, et al.
European Journal of Heart Failure|December 11, 2007
Combining the ventilatory response to exercise and peak oxygen consumption is no better than peak oxygen consumption alone in predicting mortality in chronic heart failureLee Ingle, Klaus K Witte, John G F Cleland, et al.
Journal of Cardiac Failure|October 19, 2005
Poor relationship between exercise capacity and spirometric measurements in patients with more symptomatic heart failureLee Ingle, Rhidian J Shelton, John G F Cleland, et al.
European Journal of Heart Failure|July 28, 2009
Clinical trials update from the European Society of Cardiology Heart Failure meeting 2009: CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HFJohn G F Cleland, Alison P Coletta, Azam Torabi, et al.
Journal of the American Geriatrics Society|March 18, 2014
Multiple cardiac clots in an individual with essential thrombocythemia and heart failurePierpaolo Pellicori, Anil C Joseph, Thato Mabote, et al.
European Journal of Heart Failure|August 11, 2004
Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapyAlison P Coletta, John G F Cleland, Nick Freemantle, et al.
European Journal of Heart Failure|January 3, 2006
Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVEJohn G F Cleland, Nick Freemantle, Alison P Coletta, et al.
ESC Heart Failure|February 21, 2017
Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysisJufen Zhang, Riet Dierckx, Kevin Mohee, et al.
JACC. Heart Failure|June 19, 2017
Time to Take the Failure Out of Heart Failure: The Importance of OptimismJohn G F Cleland, Pierpaolo Pellicori, Andrew L Clark, et al.
Pageof 39